`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`––––––––––––––
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`––––––––––––––
`
`
`
`SALESFORCE.COM, INC.
`Petitioner
`
`
`v.
`
`MICHAEL PHILIP KAUFMAN
`Patent Owner
`––––––––––––––
`
`U.S. Patent No. 7,885,981
`
`“Systems and Method for Generating Automatic User Interface for Arbitrary
`Complex or Large Databases”
`––––––––––––––
`
`Inter Partes Review No. 2021-00397
`
`––––––––––––––
`
`PRE-INSTITUTION REPLY TO PATENT OWNER’S PRELIMINARY
`RESPONSE TO ADDRESS FINTIV FACTORS
`
`
`
`
`
`
`Exhibit
`
`Description
`
`Ex. 1001 U.S. Patent No. 7,885,981 (“the ’981 patent”)
`
`Ex. 1002 Declaration of Dr. Benjamin Bederson (“Bederson”)
`
`Ex. 1003
`
`Ex. 1004
`
`File History of U.S. Patent No. 7,318,066 (U.S. Patent
`Application No. 10/428,209)
`
`File History of U.S. Patent No. 7,885,981 (U.S. Patent
`Application No. 11/925,236)
`
`Ex. 1005 U.S. Patent No. 5,590,190 (“Yeager”)
`
`Ex. 1006 U.S. Patent No. 6,035,300 (“Cason”)
`
`Ex. 1007
`
`Nadkarni et al., WebEAV: Automatic Metadata-driven
`Generation of Web Interfaces to Entity-Attribute-Value
`Databases, Journal of the American Medical Informatics
`Association, July/August 2000 (“Nadkarni”)
`
`Ex. 1008
`
`List of Recent Expert Witness Engagements of Dr.
`Benjamin B. Bederson
`
`Ex. 1009 Curriculum Vitae of Dr. Benjamin Bederson
`
`Ex. 1010
`
`Claim Construction and Scheduling Order, Michael Philip
`Kaufman v. Microsoft Corp., Case No. 16 Civ. 2880
`(AKH), Dkt. 69 (S.D.N.Y. Apr. 11, 2018)
`
`Ex. 1011
`
`Journal of the American Medical Informatics Association,
`WebEAV: Automatic Metadata-driven Generation of Web
`Interfaces to Entity-Attribute-Value Databases,
`https://academic.oup.com/jamia/article/7/4/343/713438
`(last visited Nov. 11, 2020)
`
`Ex. 1012
`
`ResearchGate, WebEAV: Automatic Metadata-driven
`Generation of Web Interfaces to Entity-Attribute-Value
`Databases,
`https://www.researchgate.net/publication/12432293_Web
`EAV_Automatic_Metadata-
`driven_Generation_of_Web_Interfaces_to_Entity-
`Attribute-Value_Databases (last visited Nov. 11, 2020)
`Ex. 1013 National Institutes of Health, WebEAV: Automatic
`Metadata-driven Generation of Web Interfaces to Entity-
`
`
`
`i
`
`
`
`
`
`
`Exhibit
`
`Ex. 1014
`
`Ex. 1015
`
`Ex. 1016
`
`Ex. 1017
`
`Ex. 1018
`
`Ex. 1019
`
`Description
`Attribute-Value Databases,
`https://pubmed.ncbi.nlm.nih.gov/10887163/ (last visited
`Nov. 11, 2020)
`
`Patent Owner’s Opening Claim Construction Brief in
`Michael Philip Kaufman v. Microsoft Corp., Case No. 16-
`CV-02880-AKH (S.D.N.Y.)
`
`Patent Owner’s Patent Owner Preliminary Response in
`IPR2017-01142
`
`Decision Denying Institution of Inter Partes Review, in
`IPR2017-01142
`
`Decision Denying Institution of Inter Partes Review,
`Paper 7, in IPR2017-01141
`
`Standing Order M10-468, November 30, 2020,
`https://nysd.uscourts.gov/sites/default/files/2020-
`11/20mc622%20Standing%20Order.pdf
`
`Standing Order Regarding Post-Markman Cases, Fintiv,
`Inc. v. Apple Inc., Case No. 1-19-cv-01238, Dkt. 122
`(W.D. Tex. Apr. 9, 2020)
`
`Ex. 1020
`
`Order, DivX, LLC v. Netflix, Inc., Case No. 2-19-cv-
`01602, Dkt. 106 (C.D. Cal May 11, 2020)
`
`Ex. 1021
`
`Ex. 1022
`
`Ex. 1023
`
`New York Times, New York Coronavirus Map and Case
`Count, last visited December 21, 2020,
`https://www.nytimes.com/interactive/2020/us/new-york-
`coronavirus-cases.html
`
`Law360, Trial for Ex-Giuliani Associates Delayed Again,
`November 30, 2020,
`https://www.law360.com/articles/1333129/print
`
`Law360, COVID-19 Outbreak Leads to Mistrial in EDTX,
`November 17, 2020,
`https://www.law360.com/articles/1329617/print
`
`
`
`ii
`
`
`
`
`
`
`Description
`
`Civil Case Management Plan and Scheduling Order,
`Michael Philip Kaufman v. salesforce.com, inc., Case No.
`20cv6879 (JPC), Dkt. 24 (S.D.N.Y. Oct. 26, 2020)
`
`Joint Claim Terms Chart, Michael Philip Kaufman v.
`salesforce.com, inc., Case No. 20cv6879 (JPC), Dkt. 39
`(S.D.N.Y. Dec. 9, 2020)
`
`Exhibit
`
`Ex. 1024
`
`Ex. 1025
`
`Ex. 1026
`
`DocketNavigator, Comparing scheduling order to trial
`dates
`
`Ex. 1027 DocketNavigator, Time to Milestones (nationwide)
`
`Ex. 1028 DocketNavigator, Time to Milestones (S.D.N.Y.)
`
`Ex. 1029 Declaration of Sylvia D. Hall-Ellis, Ph.D.
`
`Ex. 1030 Curriculum Vitae of Sylvia D. Hall-Ellis, Ph.D.
`
`Ex. 1031
`
`Ex. 1032
`
`Ex. 1033
`
`Ex. 1034
`
`Opinion & Order Regarding Salesforce’s Motion to
`Transfer, Kaufman v. Microsoft Corp., Case No. 16 Civ.
`2880 (AKH), Dkt. 81 (April 29, 2021)
`
`CF Traverse LLC v. Amprius, Inc., Case No. 20-cv-
`00484-RS, Dkt. 117 (N.D. Cal Nov. 6, 2020)
`
`Uniloc USA Inc. v. Apple Inc., Case No. 18-cv-00361-
`PJH, Dkt. 87 (N.D. Cal May 25, 2018)
`
`DocketNavigator, Success of Motions to Stay Pending
`Inter Partes Review (NDCA)
`
`Ex. 1035 DocketNavigator, Time to Milestones (NDCA)
`
`Ex. 1036
`
`Kaufman’s Responsive Claim Construction Brief,
`Kaufman v. Microsoft Corp., Case No. 16 Civ. 2880
`(AKH), Dkt. 59 (January 29, 2021)
`
`
`
`
`
`
`
`
`iii
`
`
`
`
`
`TABLE OF AUTHORITIES
`
`Cases
`
`Page
`
`Apple Inc. v. Fintiv, Inc.,
` IPR2020-00019, Paper 15, at 13 (PTAB May 13, 2020) ................. passim
`
`CF Traverse LLC v. Amprius, Inc.,
` Case No. 20-cv-00484-RS, Dkt. 117 (N.D. Cal Nov. 6, 2020) ................ 4
`
`SAS Institute v. Iancu,
` 138 S. Ct. 1348 (2018) ............................................................................... 4
`
`Uniloc USA Inc. v. Apple Inc.,
` Case No. 18-cv-00361-PJH, Dkt. 87 (N.D. Cal May 25, 2018) ................ 4
`
`
`
`
`
`
`
`
`iv
`
`
`
`
`
`PO is mistaken that trial is likely to occur before a final written decision
`
`(FWD). In fact, after the Petition was filed, PO filed a joint motion with
`
`Petitioner to amend the schedule in the co-pending district court litigation
`
`(“the Litigation”) that not only vacated the original July 23, 2021 trial date
`
`(and all interim case dates), but further keyed all such remaining dates off the
`
`issuance of orders on both Markman and on Salesforce’s pending motions to
`
`dismiss and strike the Compliant—with no hearings scheduled for either.
`
`Specifically, trial will occur either 207 days after a claim construction ruling
`
`or 162 days after rulings on Salesforce’s Motions to Dismiss and Strike—
`
`whichever is later. Critically, however, the Court stayed all Markman
`
`proceedings indefinitely. Thus, not only is PO’s statement that trial is “likely”
`
`to occur before a FWD incorrect, the opposite is true—trial will not occur here
`
`until months after the mentioned rulings, with no such rulings or respective
`
`hearings on the horizon. Moreover, even this schedule is now in question, as
`
`the Court just issued an order transferring the Litigation to the Northern
`
`District of California (“NDCA”), a district that has longer time-to-trial
`
`averages and routinely grants motions to stay pending IPR, like Salesforce’s
`
`pending motion. Ex. 1031.
`
`PO further ignores that there are no overlapping issues between this
`
`Petition and the Litigation. Importantly, Petitioner stipulated it would not rely
`
`
`
`1
`
`
`
`
`
`on the Petition’s cited references in the Litigation in the event of institution,
`
`allaying any concerns of inefficiency and duplicative efforts.
`
`A. Fintiv Factor 2: Proximity Of The Trial Date To FWD
`
`A trial is unlikely to occur before a FWD—as of the filing of this Reply,
`
`there is no trial date because the case was recently transferred to NDCA. The
`
`NDCA Court has yet to assign the case, let alone adopt the amended SDNY
`
`schedule or calendar hearings (e.g., Markman) that lead to rulings triggering
`
`a trial date. Trial is also unlikely to proceed in NDCA as previously scheduled
`
`in SDNY because NDCA courts average 14 months from claim construction
`
`to jury trial, placing the trial date well after a FWD. Ex. 1035.
`
`Even if the NDCA Court adopted the SDNY schedule, trial is still
`
`unlikely to occur before a FWD. The amended schedule calls for a trial date
`
`either 207 days after a claim construction ruling or 162 days after rulings on
`
`Salesforce’s Motions to Dismiss and Strike—whichever is later. Ex. 2002 at
`
`2. But no hearings have been set for these triggering events.1 PO is also
`
`
`1 Even if PO’s recently filed motion to set aside the transfer order is granted,
`
`trial is unlikely to occur for the same reasons discussed in this section, and
`
`additionally because the SDNY Court stayed consideration of Markman
`
`issues indefinitely. Ex. 1036 at 5; see Pet. at 85-86.
`
`
`
`2
`
`
`
`
`
`incorrect in suggesting a June Markman ruling would result in trial in April
`
`2022 because this fails to consider a later ruling on Salesforce’s Motions. See
`
`POPR at 6. A June Markman date is also unrealistic in view of the Court’s
`
`transfer order and PO’s challenge thereto.
`
`B.
`
`Fintiv Factor 6: Other Circumstances, Including Merits
`
`PO argues that a previous litigation and IPRs involving PO and
`
`Microsoft weigh in favor of discretionary denial. PO, however, ignores a
`
`critical fact—Petitioner was not party or an RPI to either the litigation or those
`
`IPRs. Indeed, PO alleges no relationship between Petitioner and Microsoft
`
`such that discretionary denial would be proper, nor does any exist. Tellingly,
`
`PO cites no authority to support its position that a litigation or IPRs between
`
`unrelated parties may be used to support discretionary denial.
`
`Moreover, the proceedings are substantively very different, yet another
`
`fact PO fails to address. The Microsoft litigation involved entirely different
`
`prior art, and thus, there was no opportunity for the district court in that case
`
`to evaluate the art raised here. No district court has yet had an opportunity to
`
`assess the validity of the ’981 patent in light of the Petition’s cited art.
`
`Likewise, not only did the Microsoft petitions involve different prior
`
`art, they were denied entirely on procedural grounds. One Microsoft petition
`
`was denied because Microsoft’s asserted prior art did not pre-date PO’s
`
`
`
`3
`
`
`
`
`
`asserted priority date. Ex. 1016 at 11. The other was denied because
`
`Microsoft failed to address a claim limitation regarding scanning a database,
`
`a limitation the Petition examines in depth for each ground. Ex. 1017 at 15.
`
`Finally, PO contends that the Petition should be denied because Yeager
`
`was listed on the face of the ’981 patent. However, Yeager was not raised by
`
`the examiner as the basis for any office action, nor is it cumulative of any
`
`reference cited in prosecution, and nor has there been any allegation that it is.
`
`C. Fintiv Factor 1: Likelihood Of A Stay
`
`Petitioner moved to stay the Litigation pending IPR on February 1,
`
`2021 and the issue has been fully briefed since February 23, 2021. Following
`
`transfer, this motion will be heard in NDCA, a district that commonly grants
`
`stays pending IPR. Since SAS Institute v. Iancu, 138 S. Ct. 1348 (2018),
`
`NDCA courts have granted 82% of all such motions (Ex. 1034), often before
`
`an institution decision. See, e.g., CF Traverse LLC v. Amprius, Inc., Case No.
`
`20-cv-00484-RS, Dkt. 117 (N.D. Cal Nov. 6, 2020) (staying case pending IPR
`
`institution decision) (Ex. 1032); Uniloc USA Inc. v. Apple Inc., Case No. 18-
`
`cv-00361-PJH, Dkt. 87 (N.D. Cal May 25, 2018) (Ex. 1033).
`
`D. Fintiv Factor 4: Overlap With The Parallel Proceeding
`
`PO points out that the Litigation involves the same patent as this IPR—
`
`a fact that has no bearing on this analysis and is true of every IPR filed by a
`
`
`
`4
`
`
`
`
`
`defendant of a parallel district court proceeding. PO also tellingly cites no
`
`supporting authority. Most importantly, PO wholly ignores Petitioner’s
`
`stipulation to withdraw, and not rely on, the Petition’s cited references
`
`(Yeager, Cason, and Nadkarni) in the Litigation for the ’981 patent in the
`
`event of institution. Pet. at 71-72. This waiver eliminates any overlap in
`
`invalidity issues between the Litigation and an IPR, thus alleviating any
`
`concerns of inefficiency and duplicative efforts. Id. (collecting cases).
`
`E.
`
`Fintiv Factor 3: Investment In The Parallel Proceeding
`
`The district court has invested little time in assessing the parties’ claims
`
`and defenses, and the Litigation has not materially progressed since the
`
`Petition. Although the parties have briefed a motion to dismiss the Complaint
`
`and a motion to stay, there has yet to be a ruling on either. Neither party has
`
`taken a deposition. A Markman hearing has yet to be scheduled. By the time
`
`of institution, summary judgment briefing will still be many months away.
`
`Ex. 2002 (dispositive motions deadline 141 days after Markman).
`
`For the foregoing reasons, Patent Owner’s request for discretionary
`
`denial should be rejected, and the petition instituted.
`
`
`
`
`
`
`
`
`
`5
`
`
`
`Date: May 6, 2021
`
`
`
`
`
`
`
`
`
`
` By: /s/ Jim Glass
`James M. Glass (Reg. No. 46,729)
`QUINN EMANUEL URQUHART &
`SULLIVAN LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`jimglass@quinnemanuel.com;
`Phone: 212-849-7142
`
`Ray Zado (pro hac vice to be requested
`upon grant authorization)
`Quinn Emanuel Urquhart & Sullivan,
`LLP
`555 Twin Dolphin Dr., 5th Floor
`Redwood Shores, CA 94065
`rayzado@quinnemanuel.com
`Tel: (650) 801-5000
`
`Sam Stake (pro hac vice to be requested
`upon grant authorization)
`Quinn Emanuel Urquhart & Sullivan,
`LLP
`50 California St., 22nd Floor
`San Francisco, CA 94111
`samstake@quinnemanuel.com
`Tel: (415) 875-6600
`
`Gavin Snyder (pro hac vice to be
`requested upon grant authorization)
`Quinn Emanuel Urquhart & Sullivan,
`LLP
`1109 First Avenue
`Suite 210
`Seattle, WA 98101
`gavinsnyder@quinnemanuel.com
`
`6
`
`
`
`
`
`Tel: (206) 905-7000
`
`Richard Lowry (Reg. No. 70,306)
`QUINN EMANUEL URQUHART &
`SULLIVAN LLP
`1300 I Street, NW, Suite 900
`Washington, DC 20005
`richardlowry@quinnemanuel.com;
`Phone: (202) 538-8000
`
`Counsel for Petitioner salesforce.com,
`inc.
`
`
`
`7
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE (37 C.F.R. §§ 42.6(E), 42.105(A))
`
`The undersigned hereby certifies that, on May 6, 2021 a copy of the
`
`foregoing document was served on counsel of record at the email addresses
`
`below:
`
`Ronald Abramson (Reg. No. 34,762)
`ron.abramson@listonabramson.com
`
`Ari J. Jaffess (Reg. No. 74,558)
`ari.jaffess@listonabramson.com
`
`M. Michael Lewis (Reg. No. 50,478)
`michael.lewis@listonabramson.com
`
`
`
`Date: May 6, 2021
`
` By: /s/ Richard Lowry
`Richard Lowry (Reg. No. 70,306)
`QUINN EMANUEL URQUHART &
`SULLIVAN LLP
`1300 I Street, NW, Suite 900
`Washington, DC 20005
`richardlowry@quinnemanuel.com;
`Phone: (202) 538-8000
`
`Counsel for Petitioner salesforce.com,
`inc.
`
`
`8
`
`
`
`
`
`
`
`
`
`
`
`